Cargando…
A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765793/ https://www.ncbi.nlm.nih.gov/pubmed/23957953 http://dx.doi.org/10.1186/1750-1172-8-126 |
_version_ | 1782283392236126208 |
---|---|
author | Lahiry, Piya Racacho, Lemuel Wang, Jian Robinson, John F Gloor, Gregory B Rupar, C Anthony Siu, Victoria M Bulman, Dennis E Hegele, Robert A |
author_facet | Lahiry, Piya Racacho, Lemuel Wang, Jian Robinson, John F Gloor, Gregory B Rupar, C Anthony Siu, Victoria M Bulman, Dennis E Hegele, Robert A |
author_sort | Lahiry, Piya |
collection | PubMed |
description | BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS). Neuroimaging studies identified progressive global CNS tissue loss presenting early in life, associated with microcephaly, seizures, and psychomotor retardation; based on this, we named the condition Autosomal Recessive Cerebral Atrophy (ARCA). Using two unbiased genetic approaches, homozygosity mapping and exome sequencing, we narrowed the candidate region to chromosome 11q and identified the c.995C > T (p.Thr332Met) mutation in the TMPRSS4 gene. Sanger sequencing of additional relatives confirmed that the c.995C > T genotype segregates with the ARCA phenotype. Residue Thr332 is conserved across species and among various ethnic groups. The mutation is predicted to be deleterious, most likely due to a protein structure alteration as demonstrated with protein modelling. CONCLUSIONS: This novel disease is the first to demonstrate a neurological role for a transmembrane serine proteases family member. This study demonstrates a proof-of-concept whereby combining exome sequencing with homozygosity mapping can find the genetic cause of a rare disease and acquire better understanding of a poorly described protein in human development. |
format | Online Article Text |
id | pubmed-3765793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37657932013-09-08 A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder Lahiry, Piya Racacho, Lemuel Wang, Jian Robinson, John F Gloor, Gregory B Rupar, C Anthony Siu, Victoria M Bulman, Dennis E Hegele, Robert A Orphanet J Rare Dis Research BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS). Neuroimaging studies identified progressive global CNS tissue loss presenting early in life, associated with microcephaly, seizures, and psychomotor retardation; based on this, we named the condition Autosomal Recessive Cerebral Atrophy (ARCA). Using two unbiased genetic approaches, homozygosity mapping and exome sequencing, we narrowed the candidate region to chromosome 11q and identified the c.995C > T (p.Thr332Met) mutation in the TMPRSS4 gene. Sanger sequencing of additional relatives confirmed that the c.995C > T genotype segregates with the ARCA phenotype. Residue Thr332 is conserved across species and among various ethnic groups. The mutation is predicted to be deleterious, most likely due to a protein structure alteration as demonstrated with protein modelling. CONCLUSIONS: This novel disease is the first to demonstrate a neurological role for a transmembrane serine proteases family member. This study demonstrates a proof-of-concept whereby combining exome sequencing with homozygosity mapping can find the genetic cause of a rare disease and acquire better understanding of a poorly described protein in human development. BioMed Central 2013-08-17 /pmc/articles/PMC3765793/ /pubmed/23957953 http://dx.doi.org/10.1186/1750-1172-8-126 Text en Copyright © 2013 Lahiry et al.; licensee BioMed Central Ltd. http://www.creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://www.creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Lahiry, Piya Racacho, Lemuel Wang, Jian Robinson, John F Gloor, Gregory B Rupar, C Anthony Siu, Victoria M Bulman, Dennis E Hegele, Robert A A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title | A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title_full | A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title_fullStr | A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title_full_unstemmed | A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title_short | A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder |
title_sort | mutation in the serine protease tmprss4 in a novel pediatric neurodegenerative disorder |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765793/ https://www.ncbi.nlm.nih.gov/pubmed/23957953 http://dx.doi.org/10.1186/1750-1172-8-126 |
work_keys_str_mv | AT lahirypiya amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT racacholemuel amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT wangjian amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT robinsonjohnf amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT gloorgregoryb amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT ruparcanthony amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT siuvictoriam amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT bulmandennise amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT hegeleroberta amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT lahirypiya mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT racacholemuel mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT wangjian mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT robinsonjohnf mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT gloorgregoryb mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT ruparcanthony mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT siuvictoriam mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT bulmandennise mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder AT hegeleroberta mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder |